Mati Therapeutics Inc.

CIK 1574251 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Mati Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Jul 2, 2026D/A0001574251-26-000001
Oct 8, 2025D0001574251-25-000003
Sep 23, 2025D0001574251-25-000002
May 24, 2019D0001574251-19-000001
Oct 16, 2018D0001574251-18-000001
Oct 10, 2014D0001387131-14-003415
Apr 15, 2013D0001140361-13-016447